Substance / Medication

Testosterone

Overview

Active Ingredient
testosterone
RxNorm CUI
10379
Labeler: Lupin Pharmaceuticals, Inc.Updated: 2026-01-13T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

52 trials linked to this intervention

52
Total Trials
6
Recruiting
16
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Serum total testosterone and the prognosis of patients with advanced liver disease: a systemic review and meta-analysis.
Zhang Xiao-Yu, Xu Heng-Han, Ma Jian-Hui et al. · PeerJ · 2026
PMID: 41551464Meta-AnalysisFull text (PMC)
Long-Term Cardiovascular Safety of Testosterone-Replacement Therapy in Middle-Aged and Older Men: A Meta-analysis of Randomized Controlled Trials.
Braga Marcelo A P, Rivera André, Marinheiro Gabriel et al. · Am J Cardiovasc Drugs · 2025
PMID: 40694252Meta-Analysis
Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studies.
Santucci Jordan, Stapleton Peter, Perera Marlon et al. · BJU Int · 2025
PMID: 40747831Meta-Analysis
Effects of Tribulus (L.) Supplementation on Erectile Dysfunction and Testosterone Levels in Men-A Systematic Review of Clinical Trials.
Vilar Neto José de Oliveira, de Moraes Wilson Max Almeida Monteiro, Pinto Daniel Vieira et al. · Nutrients · 2025
PMID: 40219032Meta-AnalysisFull text (PMC)
Effects of different Metabolic Bariatric Surgeries in Testosterone Levels: A Systematic Review and Meta-Analysis.
Diniz Rodrigo Pinto, Martins Ítalo Kauan Ribeiro de Carvalho, Furtado Welbert Souz et al. · Obes Surg · 2025
PMID: 40185956Meta-Analysis
Effect of testosterone formulations on hematocrit in transgender individuals: A systematic review.
Okano Sérgio Henrique Pires, Braga Giordana Campos, Cantelli Débora Aiesha Leite et al. · Andrology · 2025
PMID: 39011565Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Testosterone (substance)
SNOMED CT
43688007
UMLS CUI
C0039601
RxNorm CUI
10379
Labeler
Lupin Pharmaceuticals, Inc.

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

4
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
52
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.